Select a State

Global health R&D delivers for Kentucky

US government investment in global health R&D has delivered

$15 million
to Kentucky research institutions
150+ new jobs
for Kentucky

Neglected diseases in Kentucky

Chikungunya cases
35
Dengue cases
10
HIV diagnoses
3,058
Malaria cases
98
Tuberculosis cases
711
West Nile cases
51
Zika cases
35

Kentucky's top USG-funded global health R&D institutions

University of Louisville
$12.4 million
University of Kentucky
$2.0 million
Owensboro Medical Health System, Inc.
$494 thousand

Kentucky industry in global health R&D

Amgen
Location(s):
Louisville
ArtemiFlow
Location(s):
Lexington
Kentucky BioProcessing
Location(s):
Owensboro
MosquitoMate
Location(s):
Lexington
Vindico NanoBioTechnology
Location(s):
Lexington

Kentucky's top areas of global health R&D by USG funding

74.9%
HIV/AIDS
7.3%
Tuberculosis
6.2%
Salmonella infections
6.3%
Neglected tropical diseases
Helminths
5.2%
Other
Ebola/viral hemorrhagic fevers
Malaria
Non-allocable

Global health R&D at work in Kentucky

Researchers at the University of Tennessee and University of Louisville have discovered that a person’s gut microbes can impact the severity of malaria infection. Malaria is a mosquito-borne disease that infects more than 200 million people each year, killing almost half a million, mostly young children. There is currently no completely effective vaccine, and the parasite is growing resistant to available drug therapies. The researchers discovered that the degree of harm caused by malaria is not only a function of the parasite but is also influenced by microbes in the infected organism. This discovery opens new doors for investigation and could lead to new treatments for malaria or new approaches to improve the effectiveness of existing methods.

Footnotes